Company: RVRC
Filing Date: 2025-08-13
Form Type: S-1/A
Source: 0001213900-25-075747
Chunk: 234

Company: Revium Rx.
Filing Date: 2025-08-13
Form: S-1/A
Chunk 234
---
 December 22, 2023, the Company issued 70,312
shares of Common Stock and warrants to purchase 35,156 shares of Common Stock at the exercise price of $2.40 per shares to an accredited
investor.

On July 23, 2024, the Company issued an aggregate
of 23,171,642 Exchange Shares of the Company’s Common Stock to former shareholders of LipoVation in consideration of the contribution
of their equity ownership in LipoVation.

On December 31, 2024, the Company issued 2,800,000
shares of its Common Stock to the Chief Operating Officer upon her exercise of stock options.

These transactions were exempt from registration
under Section 4(a)(2) and/or Rule 506(b) of Regulation D and/or Regulation S as promulgated by the Securities and Exchange Commission
under the Securities Act, as transactions by an issuer not involving any public offering. None of the securities were sold through an
underwriter and, accordingly, there were no underwriting discounts or commissions involved.

ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Item 16. Exhibits and Financial Statement Schedules.

(a) Exhibits: Reference is made
to the Exhibit Index following the signature pages hereto, which Exhibit Index is hereby incorporated into this Item.

(b) Financial Statement Schedules:
All schedules are omitted because the required information is inapplicable, or the information is presented in the financial statements
and the related notes.

ITEM 17. UNDERTAKINGS

| (a) | The undersigned registrant hereby undertakes: |

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|     | -i                                                                                                                             | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|     | -ii                                                                                                                            | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation